South Korea FDA Clears Non-Citrate Sildenafil Generics For Market
This article was originally published in PharmAsia News
Executive Summary
South Korea's FDA has decided to allow generic versions of all sildenafil-based drugs, an easing of the current restriction to sildenafil citrate, which limited approval to copies of Pfizer's Viagra for treating erectile dysfunction.